The General Clinical Nuclear Medicine (GCNMC) Council is a group within SNMMI dedicated to the scientific interchange of ideas among Society members who have interest in clinical nuclear medicine issues. The overall mission of the GCNMC is to:

(a)    provide a forum for members with similar interests

(b)   provide to membership expertise in clinical nuclear medicine

(c)    foster research and education in clinical nuclear medicine

(d)   provide outreach to other professionals and organizations

(e)    nurture new membership into the Society

(f)    serve as a resource to SNMMI Leadership

Darlene Metter, MD, FACR, FACNM, FSNMMI

As the incoming President of the GCNMC, I would like to “Thank” Dr Christopher Palestro for his truly outstanding leadership as the GCNMC President for the past two years. Under his administration, the Council attained its 2nd highest membership of 349 members in 2019 (2020 data is unavailable). The Council also sponsored 7 and co-sponsored 3 CE and Categorical sessions during the 2019 Mid-Winter and Annual Meetings. Furthermore, the GCNMC is financially stable. Dr Palestro will be “a hard act to follow”, but I am confident that the GCNM “culture” of high achievement will prevail!

I look forward in continuing to promote the GCNMC Mission and its diverse practitioners in providing clinical expertise and the promotion of research and education in general clinical nuclear medicine, remain a resource for the SNMMI leadership, and provide professional collaboration and outreach for our internal and external stakeholders. Lastly, the future of our specialty requires the nurturing of our current and emerging professionals to include our nuclear medicine technologists. “Thank you” for the honor of being your GCNMC President.

Respectfully,

Darlene Metter MD, FACR, FACNM, FSNMMI
President, General Clinical Nuclear Medicine Council

How to Become a Member
Membership in the General Clinical Nuclear Medicine Council is limited to members of the SNMMI. Membership can be attained by indicating the desire to join during the annual renewal of the SNMMI membership or by filing an application with the Secretary of the council.

Payment of Dues
Membership in the GCNMC requires payment of dues in the amount of $20/year. Dues are paid to SNMMI and will be due on October 1st of each year.

Benefits of Membership:
Membership makes you a part of a professional group within the SNMMI that:

Provides continuing education for professionals in the various areas relating to through sponsored symposia and continuing education courses. Each year the GCNMC puts on a Categorical Seminar or symposia, and Continuing Education Courses on topics of interest to professionals in the clinical nuclear medicine.

Provides a forum and a mechanism for discussion and dissemination of information relating to the clincal nuclear medicine. The GCNMC members receive periodic Newsletters and electronic mailings containing information on professional activities, government issues, and a host of other topics related to clinical nuclear medicine. Members will soon have access to GCNMC Web pages and e-communicites, which will contain timely and archived information relating to a variety of topics in clinical nuclear medicine.

Provides expertise in clinical nuclear medicine to SNMMI leadership and to groups outside of SNMMI seeking such expertise. The GCNMC has representation in a number of governance groups within SNMMI, including the Committee on Councils and the House of Delegates.

Learn more about the specific benefits the GCNMC council has to offer by emailing memberinfo@snmmi.org 

 

GCNMC Lifetime Achievement Award

The GCNMC Lifetime Achievement Award is established to recognize those physicians and scientists who have distinguished themselves through a career dedicated to the advancement of patient care through the field of nuclear medicine. These individuals will have provided outstanding contributions to the general nuclear medicine subspecialties including urogenital, pulmonary, musculoskeletal, endocrine and gastrointestinal imaging that have advanced the field to allow improved clinical diagnosis and patient care. 

The recipient of this year’s GCNMC Lifetime Achievement Award is Shankar Vallabhajosula, PhD. Born in south India, Dr. Vallabhajosula received his BS and MS degrees in pharmaceutical sciences from Andhra University. After immigrating to United States in 1974, he began his career as a nuclear medicine technologist working in New York. In 1976 he joined the biomedicinal chemistry and Radiopharmacy program at the University of Southern California where he obtained his PhD under the supervision of Dr. Walter Wolf. In his doctoral dissertation, he demonstrated that the tumor glycolysis (Warburg effect) is responsible for the mechanism of tumor uptake of 67Ga-citrate. In 1980, he began his 40-year long collaboration with Stanley J. Goldsmith, M.D. (former president of the SNM and editor of the JNM); first at Mount Sinai Medical Center and later at Weill Cornell Medicine in New York. Throughout his professional career, Dr. Vallabhajosula has been dedicated to the advancement of patient care through nuclear medicine. He made significant contributions to the development of radiopharmaceuticals for both imaging and targeted radionuclide therapy (TRT). Dr. Vallabhajosula published more than 120 articles in major scientific journals and was responsible for obtaining 20 INDs for PET and therapy radiopharmaceuticals. In 2004, he received an NDA for the manufacture of [18F]FDG at Weill Cornell Medicine.

Dr. Vallabhajosula has been an active member of the SNM and the ABSNM. He served as the associate editor of the Journal of Nuclear Medicine (1994-1998). He received the Berson and Yalow award in 2007 by the Greater New York Chapter of Nuclear Medicine for his contributions to the basic and clinical science of nuclear medicine. In 2009, he published a single author textbook titled “Molecular Imaging: Radiopharmaceuticals for PET and SPECT” (published by Springer Verlag). A second and revised edition titled “Molecular Imaging and Targeted Radionuclide Therapy: Radiopharmaceuticals and Clinical Applications” is scheduled to be published by Springer Verlag in 2022. Dr. Vallabhajosula is Professor Emeritus at Weill Cornell Medicine of Cornell University, New York, NY.

Congratulations, Dr. Vallabhajosula!

 

Shankar Vallabhajosula, PhD

Past Lifetime Achievement Award
2015: Naomi Alazraki, MD
2016: Leonard Freeman, MD
2017: Stanley Goldsmith, MD
2018: Eva Dubovsky, MD
2019: Christopher Palestro, MD
2020: Ora Israel, Sr., MD, FSNMMI
2021: Harvey Ziessman, MD

 

GCNMC Lectureship Award

The Council strives to improve GCNM practice by providing continuing education, and seeks to instill camaraderie and pride in GCNM practitioners. The GCNM Lectureship recognizes an individual whose research, publications, teaching or clinical practice has furthered the use of, and who can present insights on the value of general clinical nuclear medicine procedures.

The 2022 GCNMC Lectureship awardee is Christopher Palestro, MD, FACNM, FSNMMI

An internationally recognized authority on molecular imaging of infection, Christopher J. Palestro, MD, FSNMMI, FACNM, Professor of Radiology at the Zucker School Of Medicine at Hofstra/Northwell, has published nearly two hundred peer reviewed articles and 100 reviews/chapters and has lectured around the world. He has been a reviewer for the Journal of Nuclear Medicine, European Journal of Nuclear Medicine & Molecular Imaging, and Radiology, among others. Dr. Palestro has been an associate editor of Radiology, and currently serves on the editorial boards of the Journal of Nuclear Medicine, Quarterly Journal of Nuclear Medicine and Molecular Imaging and Hemato. A life member and past chair of the American Board of Nuclear Medicine, Dr. Palestro also has chaired the ACGME Nuclear Medicine Residency Review Committee and the United States Nuclear Regulatory Commission’s Advisory Committee on Medical Uses of Isotopes. He has received the SNMMI’s Presidential Distinguished Educator Award and at the present time chairs the Society’s AUC Workgroup for Imaging Infection as well as the Value Initiative’s Workforce Pipeline Domain.

Congratulations Dr Palestro!

 

Christopher Palestro, MD, FACNM, FSNMMI

 

 

Past GCNMC Lectureship Award Recipients
2018: William Leslie, MD
2019: Anca Avram, MD
2020: Herbert Chen, MD, FACS
2021: Philip Wells, MD, FRCPC, MSc

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Governance

The Society recognizes the need for sub-specialty interests/expertise within the field of nuclear medicine and moleuclar imaging. Councils provide the expertise, professional networking and educational programs for nuclear medicine professionals in respective areas and serve as a resource for development and implementatin of Society policies.

Council membership is voluntary. Councils adhere to Society Bylaws and policies, while operating under its own Operating Procedures, as approved by the House of Delegates, and its own business plan and budget, as approved by the SNMMI Board of Directors.

This section provides the following council specific information.

GCNMC Board of Directors
GCNMC Operating Procedures
GCNMC Business Plan
GCNMC Council Reports to the House of Delegates
GCNMC Past Presidents

GCNMC Lifetime Achievement Award
The award recognizes those physicians and scientists who have distinguished themselves through a career dedicated to the advancement of patient care through the field of nuclear medicine

2015: Naomi Alazraki, MD
2016: Leonard Freeman, MD
2017: Stanley Goldsmith, MD
2018: Eva Dubovsky, MD
2019: Christopher Palestro, MD
2020: Ora Israel, MD
2021: Harvey Ziessman, MD

GCNMC Lectureship Award
This award recognizes an individual whose research, publications, teaching or clinical practice has furthered the use of, and who can present insights on, the value of general clinical nuclear medicine procedures

2018: William Leslie, MD - The Role of Nuclear Medicine in Osteoporosis: Past, Present, Future
2019: Anca Avram, MD - The evolving paradigm of radioiodine therapeutics for thyroid cancer   
2020: Herbert Chen, MD - Radioguided Techniques during Parathyroid Surgery
2021: Philip Wells, MD, FRCPC, MSc

GCNMC Mid-Winter and Annual Meeting Education Sessions
2014 Annual Meeting
2015 Mid-Winter Meeting and Annual Meeting
2016 Mid-Winter and Annual Meeting
2017 Mid-Winter and Annual Meeting
2018 Annual Meeting
2019 Annual Meeting
2020 Annual Meeting - Virtual Edition
2021 Mid-Winter Meeting - Virtual Edition
2021 Annual Meeting - Virtual Edition
2022 Mid-Winter Meeting - Virtual Edition
2022 Annual Meeting


GCNMC Announcements

SNMMI Fall Therapeutics Conference

November 17-19, 2022 | Washington, DC (National Harbor)

Make your plans to attend the SNMMI Fall Therapeutics Conference, November 17-19, 2022 at the Gaylord National Resort and Convention Center, moments from Washington, DC. This two-and-a-half-day event will explore the latest innovations and clinical applications in radiopharmaceutical therapy. Get notified when program information/registration become available.

Meeting website


2023 SNMMI Mid-Winter and ACNM Annual Meeting

January 26-28, 2023 | San Francisco, CA

The 2023 SNMMI Mid-Winter and ACNM Annual Meeting—January 26-28 in San Francisco, CA—will feature three educational tracks highlighting the latest innovations and techniques in the field, including a dedicated track on neuroimaging.

Now Open: ACNM invites you to submit an original clinical or scientific abstract for the opportunity to present your research during the 2023 SNMMI Mid-Winter and ACNM Annual Meeting.

Meeting website 

GCNMC CE Sessions

Molecular Imaging of Fever of Unknown Origin in Adults and Children (co-sponsored by the Pediatric Imaging Council)
Saturday, January 28, 8:00 – 10:00 am

How to Keep Out of Trouble in Clinical Nuclear Medicine:  The Legal Issues
Saturday, January 28, 1:30 – 3:30 pm


Join the General Clinical Nuclear Medicine Council

Council membership is voluntary. Society members are eligible for council membership, and can belong to as many councils as they wish. The General Clinical Nuclear Medicine Council dues are $20.00. Join this council




General Clinical Nuclear Medicine Council Activities

2022 SNMMI Annual Meeting GCNMC Education Sessions 

Saturday, June 11; 7:30 am – 3:00 pm 
CAT01: A New Decade Molecular Hybrid Imaging in Orthopedics and Rheumatology: Focus on bone and infection/inflammation 

Sunday, June 12; 12:30 – 2:00 PM 
CE14:  Organ Transplant Scintigraphy 

Saturday, June 11; 1:30 – 3:00 PM  
CE04:  COVID Session 

Tuesday, June 14; 8:00 – 9:00 PM 
CE45:  GCNMC Annual Award Lectureship